Abstract
Despite chemotherapy and intended curative surgery, approximately 50% of patients with gastric cancer develop recurrence and eventually die of metastatic disease. The detection of circulating tumour cells (CTC) in peripheral blood is a promising prognostic and predictive marker. The most typically applied approaches to the detection of CTC are RT-PCR and immunological assays. Measurement of CTC in gastric cancer seems useful for predicting prognosis and monitoring response of chemotherapy. There is still no gold standard for CTC-detection in gastric cancer patients and larger studies are needed.
Translated title of the contribution | Circulating tumour cells is a promising prognostic and predictive marker of gastric cancer. |
---|---|
Original language | Danish |
Article number | V01130083 |
Journal | Ugeskrift for Laeger |
Volume | 176 |
Issue number | 16 |
Pages (from-to) | 1490-1493 |
Number of pages | 4 |
ISSN | 0041-5782 |
Publication status | Published - 4 Aug 2014 |